FI970109L - Vesipitoisia risperidonikoostumuksia - Google Patents

Vesipitoisia risperidonikoostumuksia Download PDF

Info

Publication number
FI970109L
FI970109L FI970109A FI970109A FI970109L FI 970109 L FI970109 L FI 970109L FI 970109 A FI970109 A FI 970109A FI 970109 A FI970109 A FI 970109A FI 970109 L FI970109 L FI 970109L
Authority
FI
Finland
Prior art keywords
risperidone compositions
aqueous
aqueous risperidone
compositions
risperidone
Prior art date
Application number
FI970109A
Other languages
English (en)
Swedish (sv)
Other versions
FI970109A0 (fi
FI116510B (fi
Inventor
Marc Karel Jozef Francois
Willy Maria Albert Dries
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26955530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI970109(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI970109L publication Critical patent/FI970109L/fi
Publication of FI970109A0 publication Critical patent/FI970109A0/fi
Application granted granted Critical
Publication of FI116510B publication Critical patent/FI116510B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI970109A 1994-07-11 1997-01-10 Vesipitoisia risperidonikoostumuksia FI116510B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/272,462 US5453425A (en) 1994-07-11 1994-07-11 Risperidone oral formulation
US27246294 1994-07-11
US08/429,435 US5616587A (en) 1994-07-11 1995-04-26 Aqueous risperidone formulations
US42943595 1995-04-26
PCT/EP1995/002615 WO1996001652A1 (en) 1994-07-11 1995-07-04 Aqueous risperidone formulations
EP9502615 1995-07-04

Publications (3)

Publication Number Publication Date
FI970109L true FI970109L (fi) 1997-01-10
FI970109A0 FI970109A0 (fi) 1997-01-10
FI116510B FI116510B (fi) 2005-12-15

Family

ID=26955530

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970109A FI116510B (fi) 1994-07-11 1997-01-10 Vesipitoisia risperidonikoostumuksia

Country Status (36)

Country Link
US (3) US5453425A (fi)
EP (1) EP0769965B1 (fi)
JP (1) JP2872412B2 (fi)
KR (1) KR100212942B1 (fi)
CN (1) CN1148226C (fi)
AP (1) AP774A (fi)
AT (1) ATE206931T1 (fi)
AU (1) AU684193B2 (fi)
BG (1) BG63070B1 (fi)
BR (1) BR9508253A (fi)
CA (1) CA2194564C (fi)
CY (1) CY2268B1 (fi)
CZ (1) CZ285204B6 (fi)
DE (1) DE69523313T2 (fi)
DK (1) DK0769965T3 (fi)
EE (1) EE03426B1 (fi)
ES (1) ES2165918T3 (fi)
FI (1) FI116510B (fi)
HR (1) HRP950397B1 (fi)
HU (1) HU222352B1 (fi)
IL (1) IL114525A (fi)
MX (1) MX9700374A (fi)
MY (1) MY114389A (fi)
NO (1) NO320366B1 (fi)
NZ (1) NZ289432A (fi)
PH (1) PH31626A (fi)
PL (1) PL179972B1 (fi)
PT (1) PT769965E (fi)
RO (1) RO116778B1 (fi)
RU (1) RU2161965C2 (fi)
SI (1) SI9500220B (fi)
SK (1) SK282159B6 (fi)
TR (1) TR199500778A1 (fi)
TW (1) TW420615B (fi)
WO (1) WO1996001652A1 (fi)
ZA (1) ZA955720B (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434258T2 (de) * 1993-11-19 2006-01-19 Janssen Pharmaceutica N.V. Mikroverkapselte 1,2-benzazole
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
SE0103211D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1534288A1 (en) * 2002-08-23 2005-06-01 Ranbaxy Laboratories, Ltd. Stable aqueous solutions of risperidone and methods for their preparation
EP1615923A1 (en) * 2003-04-22 2006-01-18 Synthon B.V. Risperidone monohydrochloride
AR044852A1 (es) 2003-06-24 2005-10-05 Novartis Ag Una composicion farmaceutica para la administracion parenteral que comprende un analogo de somatostatina
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
ES2245252B1 (es) * 2004-06-15 2007-03-01 Farmalider, S.A. Solucion acuosa de risperidona para administracion oral.
ES2245891B1 (es) * 2004-07-09 2006-11-16 Clinmet S.L. "metodo para la obtencion de un excipiente universal para la administracion oral de principios activos farmaceuticos y composiciones de excipientes resultantes del metodo".
WO2006129160A2 (en) * 2005-06-01 2006-12-07 Aurobindo Pharma Limited Stable aqueous oral solution of risperidone
ES2323286T3 (es) * 2005-06-29 2009-07-10 Verisfield (Uk) Ltd. Composiciones farmaceuticas de risperidona en disolucion acuosa.
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
JP4922657B2 (ja) * 2006-05-09 2012-04-25 高田製薬株式会社 リスペリドン経口用液剤
WO2007138462A2 (en) * 2006-06-01 2007-12-06 Wockhardt Ltd Aqueous oral formulations of risperidone
CN101801415B (zh) 2007-05-25 2015-09-23 Rb医药品有限公司 利培酮化合物的持续递送制剂
US7776866B2 (en) * 2007-09-15 2010-08-17 Protia, Llc Deuterium-enriched risperidone
HUE053904T2 (hu) * 2007-12-19 2021-07-28 Janssen Pharmaceutica Nv Hosszan tartó hatású injektálható paliperidon-észterekkel kapcsolatos adagolási rendek
MX353752B (es) 2009-01-20 2018-01-26 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Los ácidos sórbico y benzoico y sus derivados aumentan la actividad de un neurofármaco.
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
AU2012321345B2 (en) * 2011-10-03 2016-03-17 The University Of Utah Research Foundation Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
AU2015341490C1 (en) 2014-11-07 2021-03-11 Indivior Uk Limited Buprenorphine dosing regimens
RU2765625C2 (ru) 2016-06-13 2022-02-01 Сайньюрекс Интернэшнл (Тайвань) Корп. Сокристаллы бензоата лития и их применения
ES2936094T3 (es) 2016-06-13 2023-03-14 Syneurx Int Taiwan Corp Cocristales de benzoato de sodio y usos de los mismos
CA3037531A1 (en) * 2016-09-23 2018-03-29 Delpor, Inc. Compositions for small molecule therapeutic agent compounds
US10336679B2 (en) 2016-10-24 2019-07-02 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
RU2646812C1 (ru) * 2016-10-24 2018-03-07 Общество с ограниченной ответственностью "Трейдсервис" Жидкая лекарственная форма рисперидона и способ ее получения
US11369579B2 (en) 2016-10-24 2022-06-28 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
CN107260662A (zh) * 2017-06-21 2017-10-20 南京正科医药股份有限公司 一种利培酮口服溶液及其制备方法
CN107441037A (zh) * 2017-08-16 2017-12-08 南京正科医药股份有限公司 一种利培酮口服溶液
CN109589304A (zh) * 2017-10-01 2019-04-09 万特制药(海南)有限公司 利培酮口服溶液及其制备方法
US10098861B1 (en) 2017-10-24 2018-10-16 Syneurx International (Taiwan) Corp. Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof
CN112004538A (zh) * 2018-02-27 2020-11-27 德尔宝股份有限公司 小分子治疗剂化合物的组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337261A (en) * 1980-07-28 1982-06-29 Hoechst-Roussel Pharmaceuticals Inc. (1,2-Benzisoxazol)phenoxyacetic acids as diuretics
US4793992A (en) * 1987-03-25 1988-12-27 Redken Laboratories, Inc. Hair treatment composition
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
FR2641278B1 (fr) * 1989-01-05 1991-03-22 Lipha Piperidines, procedes de preparation et medicaments les contenant
DK203990D0 (da) * 1990-08-24 1990-08-24 Novo Nordisk As Piperazinylderivater
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation
FR2796273B1 (fr) * 1999-07-15 2003-09-12 Oreal Composition a phase grasse liquide gelifiee par un polyamide a groupements ester terminaux

Also Published As

Publication number Publication date
NO970051D0 (no) 1997-01-07
SI9500220B (sl) 2004-12-31
MX9700374A (es) 1997-04-30
PT769965E (pt) 2002-04-29
AP9700910A0 (en) 1997-01-31
KR100212942B1 (ko) 1999-08-02
CA2194564A1 (en) 1996-01-25
NZ289432A (en) 1998-05-27
TR199500778A1 (tr) 1996-10-21
EE9700009A (et) 1997-08-15
EE03426B1 (et) 2001-06-15
NO320366B1 (no) 2005-11-28
CZ285204B6 (cs) 1999-06-16
DK0769965T3 (da) 2002-02-04
AP774A (en) 1999-10-28
RO116778B1 (ro) 2001-06-29
CA2194564C (en) 1997-12-16
KR970704472A (ko) 1997-09-06
ZA955720B (en) 1997-01-10
USRE39181E1 (en) 2006-07-11
EP0769965A1 (en) 1997-05-02
EP0769965B1 (en) 2001-10-17
HRP950397A2 (en) 1997-10-31
HUT76826A (en) 1997-11-28
PL179972B1 (pl) 2000-11-30
JPH09511751A (ja) 1997-11-25
NO970051L (no) 1997-01-07
BG101106A (en) 1997-08-29
WO1996001652A1 (en) 1996-01-25
CY2268B1 (en) 2003-07-04
HRP950397B1 (en) 2002-04-30
CN1148226C (zh) 2004-05-05
BG63070B1 (bg) 2001-03-30
CZ2797A3 (en) 1997-07-16
HU9700082D0 (en) 1997-02-28
DE69523313D1 (de) 2001-11-22
AU684193B2 (en) 1997-12-04
US5616587A (en) 1997-04-01
PH31626A (en) 1999-01-12
AU2927595A (en) 1996-02-09
FI970109A0 (fi) 1997-01-10
PL318132A1 (en) 1997-05-12
BR9508253A (pt) 1997-12-23
FI116510B (fi) 2005-12-15
IL114525A0 (en) 1995-11-27
SI9500220A (en) 1996-02-29
HU222352B1 (hu) 2003-06-28
MY114389A (en) 2002-10-31
SK2297A3 (en) 1997-09-10
US5453425A (en) 1995-09-26
CN1155247A (zh) 1997-07-23
ES2165918T3 (es) 2002-04-01
SK282159B6 (sk) 2001-11-06
JP2872412B2 (ja) 1999-03-17
DE69523313T2 (de) 2002-06-27
IL114525A (en) 1999-06-20
ATE206931T1 (de) 2001-11-15
TW420615B (en) 2001-02-01
HK1010691A1 (en) 1999-06-25
RU2161965C2 (ru) 2001-01-20

Similar Documents

Publication Publication Date Title
ATE206931T1 (de) Waessrige risperidone-zusammensetzungen
FI915209A7 (fi) Vesipitoisia koostumuksia
NO961322D0 (no) Interferoninneholdende vandig sammensetning
BR9404552A (pt) Composição aquosa
DE69512553D1 (de) Wässrige Beschichtungszusammensetzung
FI955353L (fi) Vesipitoinen hopeakoostumus
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
DE69920730D1 (de) Wässrige zusammensetzung
DE69824822D1 (de) Wässerige Antischaumzusammensetzungen
DE69732787D1 (de) Wässrige körperreinigungsmittelzusammensetzung
EP0708091A3 (en) Indoloyl-guanidines derivatives
FI954154L (fi) Gepiroonikoostumuksia
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
DE69621039D1 (de) Wässrige silikat-zusammensetzungen
DE69512702D1 (de) Wässrige Tintezusammensetzung
DE69822366D1 (de) Wässrige Emulsionszusammensetzung
DE69524611D1 (de) Pyrimidon-derivate
FI934687L (fi) Vattenhaltiga komposition
DE69500605D1 (de) Wässrige Primerzusammensetzung
BR9702241A (pt) Composição aquosa
DE69500604D1 (de) Wässrige Primerzusammensetzung
FI972795A7 (fi) Pyrimidiinijohdannaisia
DE69832127D1 (de) Wässrige Siliconzusammensetzung
DE69510792D1 (de) Naphtochinonderivate
DE59509209D1 (de) Diphenyloxazolin-derivate

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116510

Country of ref document: FI

MA Patent expired